Back to Search
Start Over
Rituximab in a risk‐adapted treatment strategy gives excellent therapeutic results in nodular lymphocyte‐predominant Hodgkin lymphoma.
- Source :
- British Journal of Haematology; Sep2018, Vol. 182 Issue 5, p715-718, 4p, 1 Diagram, 1 Chart
- Publication Year :
- 2018
- Subjects :
- RITUXIMAB
HODGKIN'S disease treatment
NODULAR disease
THERAPEUTICS
Subjects
Details
- Language :
- English
- ISSN :
- 00071048
- Volume :
- 182
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- British Journal of Haematology
- Publication Type :
- Academic Journal
- Accession number :
- 131393465
- Full Text :
- https://doi.org/10.1111/bjh.14856